About AgencyIQ

Alexander Gaffney is the Executive Director of Life Sciences at POLITICO’s AgencyIQ, where he leads the team’s research and analysis of life sciences regulatory issues affecting the Food and Drug Administration. He also leads the team’s business development activities.  

Alexander previously worked at PricewaterhouseCoopers where he led the firm’s analysis of life sciences regulatory issues as part of its Health Research Institute. Before joining PwC, he was the Manager of Regulatory Intelligence at the Regulatory Affairs Professionals Society (RAPS), where he also was Managing Editor of the company’s flagship publication, Regulatory Focus. Alexander has a master’s degree in Regulatory Science from the University of Maryland and has held his Regulatory Affairs Certification (RAC) in US regulation since 2013. He also has a degree in Political Science from Providence College. He currently lives in the Washington, DC area with his wife and two dogs. 

Laura DiAngelo is a Senior Research Manager at AgencyIQ’s Life Sciences division. Laura specializes in regulatory issues related to medical devices, diagnostics, digital health and novel data sources. 

Prior to joining AgencyIQ, Laura worked in regulatory and government affairs consulting, advising both life sciences and payer clients on federal policy issues and coordinating business intelligence activities. Laura received a Masters of Public Health (MPH) from George Washington University (Washington, DC) in 2017.  

Kedest Tadesse is a Senior Research Manager and contributes to the research and development of content for pharmaceutical and biologic products at AgencyIQ’s Life Sciences division.  

Prior to joining AgencyIQ, Kedest worked on issues related to the development, regulation, and litigation of foods, drugs, and medical devices, including the coordination and compilation of regulatory submissions to the FDA. Kedest also provided support in responding to various legislative challenges to consumer and industrial products. Kedest received a B.S. in Biochemistry and Cell Biology from Jacobs University (Bremen, Germany) and a M.S. in Biotechnology from Georgetown University (Washington, DC). Kedest also holds a Regulatory Affairs Certification (RAC) in US regulation. 

Kirsten Messmer, PhD, RAC is a Senior Research Analyst and contributes to the research and development of content for AgencyIQ on regulatory issues affecting pharmaceutical and biopharmaceutical companies in the United States and the European Union.  

Prior to joining Agency IQ, Kirsten was a Principal Regulatory Affairs Specialist at PPD providing global regulatory intelligence to support efficient, compliant and successful clinical research and drug development for biopharmaceuticals and advanced therapies. Before starting at PPD, Kirsten worked at Theradigm to develop stem cell therapies for neurodegenerative diseases before joining ERA Consulting. She held post-doctoral fellowships in London and Baltimore.  

Kirsten received her PhD in Neuroscience from the University of Sheffield (Sheffield, UK) and a Biology Diploma from the Eberhard-Karls University (Tübingen, Germany). Kirsten also holds a Regulatory Affairs Certification (RAC) in US regulation.

Corey Jaseph is a senior research analyst at POLITICO’s AgencyIQ. She performs research and analysis on medical device regulatory issues for the United States and the European Union. 

Prior to AgencyIQ, Corey worked in a regulatory capacity for both diagnostic and medical device manufacturing companies for over 20 years, both in compliance and pre-market regulatory planning.  She has performed recalls, filed medical device reports, created device regulatory plans, and authored premarket submissions, including 510(k)s, 513(g)s, IDEs, and PMA annual reports.  Corey has also written submissions and technical files for Canada and the European Union. Corey has a master’s degree in biomedical writing from the University of the Sciences in Philadelphia, and a bachelor’s degree from University of California Berkeley. Corey has held a Regulatory Affairs Certification (RAC) in US regulation since 2006. She lives near Sacramento, California, with her husband and rescue dog, Sophie. 

Lily Rosenfield is a Research Analyst for AgencyIQ focused on evaluating qualitative and quantitative data for life sciences companies as well as key regulatory issues related to generic drug products, over-the-counter drugs and dietary supplements.  

Prior to joining AgencyIQ, Lily worked as a Senior Consultant at Booz Allen Hamilton, and as a researcher for the Advisory Board Company (now part of Optum). Her expertise spans multiple areas of health policy, and she has worked closely with healthcare providers, life sciences companies and government agencies. She received her B.A. in Environmental Science from George Washington University in Washington, D.C., where she still resides today.